LEVETIRAM levetiracetam 1000mg film coated tablet blister pack

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

levetiracetam, Quantity: 1000 mg

Disponível em:

Strides Pharma Science Pty Ltd

DCI (Denominação Comum Internacional):

Levetiracetam

Forma farmacêutica:

Tablet, film coated

Composição:

Excipient Ingredients: titanium dioxide; hypromellose; povidone; crospovidone; magnesium stearate; colloidal anhydrous silica; purified talc; macrogol 400

Via de administração:

Oral

Unidades em pacote:

10 tablets, 100 tablets, 60 tablets

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Levetiracetam film-coated tablets are indicated for: ? use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation, ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy (JME), and ? add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (IGE).

Resumo do produto:

Visual Identification: White colour, oval shaped film coated tablets with break line on one side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius

Status de autorização:

Registered

Data de autorização:

2012-04-17